A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared
With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative
Colitis (UC)
Research Question:
Does the drug UTR1147A help patients with ulcerative colitis?
Basic Study Information
Purpose:
This study is designed to evaluate the efficacy, safety, and pharmacokinetics of UTTR1147A
compared with vedolizumab and with placebo in the treatment of participants with moderate
to
severe UC. This study will consist of two parts, Part A and Part B. Part A will test
the
induction of clinical remission and Part B will test the durability of clinical remission.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher: Lawrence Saubermann
Study Contact Information
Study Coordinator: Reference Study ID: GA39925 www.roche.com/about_roche/roche_worldwide.htm
Phone: (888) 662-6728
Email: global-roche-genentech-trials@gene.com
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search